Abstract |
Receptor activator of NF-kappaB ligand (RANKL) plays an essential role in osteoclast formation and bone resorption. Although genetic and biochemical studies indicate that RANKL regulates osteoclast differentiation by activating receptor activator of NF-kappaB and associated signaling molecules, the molecular mechanisms of RANKL-regulated osteoclast differentiation have not yet been fully established. We investigated the role of the transcription factor c-Jun, which is activated by RANKL, in osteoclastogenesis using transgenic mice expressing dominant-negative c-Jun specifically in the osteoclast lineage. We found that the transgenic mice manifested severe osteopetrosis due to impaired osteoclastogenesis. Blockade of c-Jun signaling also markedly inhibited soluble RANKL-induced osteoclast differentiation in vitro. Overexpression of nuclear factor of activated T cells 1 (NFAT1) (NFATc2/NFATp) or NFAT2 (NFATc1/NFATc) promoted differentiation of osteoclast precursor cells into tartrate-resistant acid phosphatase-positive (TRAP-positive) multinucleated osteoclast-like cells even in the absence of RANKL. Overexpression of NFAT1 also markedly transactivated the TRAP gene promoter. These osteoclastogenic activities of NFAT were abrogated by overexpression of dominant-negative c-Jun. Importantly, osteoclast differentiation and induction of NFAT2 expression by NFAT1 overexpression or soluble RANKL treatment were profoundly diminished in spleen cells of the transgenic mice. Collectively, these results indicate that c-Jun signaling in cooperation with NFAT is crucial for RANKL-regulated osteoclast differentiation.
|
Authors | Fumiyo Ikeda, Riko Nishimura, Takuma Matsubara, Sakae Tanaka, Jun-ichiro Inoue, Sakamuri V Reddy, Kenji Hata, Kenji Yamashita, Toru Hiraga, Toshiyuki Watanabe, Toshio Kukita, Katsuji Yoshioka, Anjana Rao, Toshiyuki Yoneda |
Journal | The Journal of clinical investigation
(J Clin Invest)
Vol. 114
Issue 4
Pg. 475-84
(Aug 2004)
ISSN: 0021-9738 [Print] United States |
PMID | 15314684
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anthracenes
- Carrier Proteins
- DNA-Binding Proteins
- Membrane Glycoproteins
- NFATC Transcription Factors
- Nfatc1 protein, mouse
- Nfatc2 protein, mouse
- Nuclear Proteins
- Proto-Oncogene Proteins c-jun
- RANK Ligand
- Receptor Activator of Nuclear Factor-kappa B
- Tnfrsf11a protein, mouse
- Tnfsf11 protein, mouse
- Transcription Factors
- pyrazolanthrone
|
Topics |
- Adenoviridae
(genetics)
- Animals
- Animals, Newborn
- Anthracenes
(pharmacology)
- Bone Marrow Cells
(cytology, drug effects, metabolism)
- COS Cells
- Carrier Proteins
(genetics, metabolism, pharmacology)
- Cell Differentiation
- Cell Line
- Cell Lineage
- Chlorocebus aethiops
- DNA-Binding Proteins
(metabolism)
- Enzyme Activation
(drug effects)
- Gene Expression Regulation
- Genes, Reporter
- Membrane Glycoproteins
(genetics, metabolism, pharmacology)
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Monocytes
(cytology, drug effects, metabolism)
- NFATC Transcription Factors
- Nuclear Proteins
- Osteoclasts
(drug effects, metabolism, pathology)
- Promoter Regions, Genetic
- Proto-Oncogene Proteins c-jun
(genetics, metabolism)
- RANK Ligand
- Receptor Activator of Nuclear Factor-kappa B
- Signal Transduction
(drug effects)
- Transcription Factors
(metabolism)
- Transcriptional Activation
|